The annual reports of 32 listed companies disclosed that 10 billion private placement of 8.5 billion heavy warehouse shares surfaced, favoring the pharmaceutical and chemical industries

With the disclosure of the annual reports of listed companies, the heavy positions of private securities investment funds have also surfaced. According to the statistics of private placement network, as of March 18, 22 products of 10 billion securities private placement appeared in the list of the top 10 tradable shares of 32 listed companies that have disclosed the annual reports, with a total holding market value of more than 8.544 billion yuan. From the perspective of shareholding changes, there are 14 new listed companies, 3 listed companies with reduced holdings and 2 listed companies with increased holdings. From the industry distribution of 10 billion private placement heavy positions, as of the disclosed data, the number of pharmaceutical, biological and basic chemical stocks is the largest, with 6.

the number of 10 billion private placements remained unchanged at 116, and the private placements of futures and bonds were positive

The continuously depressed market makes it difficult to raise funds. Compared with 2021, there are not many burst funds in 2022. The slowdown of incremental funds and the decline of performance also have an impact on the management scale of private placement. However, as of March 20, the data of 10 billion private placement remained unchanged.

From the performance of 10 billion private placement, the average return during the year was - 8.78%. Only eight 10 billion private placements, including Qianxiang assets, Luoshu investment, black wing assets, Zhanhong investment, jiuying assets, qiaoshui (China) investment, Sixie investment and Mingyi fund, achieved positive returns this year, mostly managed futures or bond strategy private placements, and CTA funds generally achieved good returns.

Liu Youhua, research director of private placement network, analyzed that this is because CTA strategy invests in commodity futures, which has low correlation with stocks, bonds and other types of hedge funds, which can disperse the risk of the overall portfolio. The combination of strategy and effective market environment can reduce the risk of CTA failure at the same time. CTA strategy is also a sharp weapon to deal with the bull market. From the historical data, it has performed well in 2022, which won the conflict with Russia and Ukraine during the subprime mortgage crisis in 2008, the sharp fluctuation of A-Shares in 2015, and the covid-19 pneumonia epidemic in 2020.

Taking advantage of CTA's anti risk strategy, there are also 10 billion quantitative private placement in the current market to actively prepare for the issuance of new products of "CTA + quantitative stock selection". For such products, CTA's income and anti risk ability are fully retained, and quantitative stock selection can be used to grasp the expectation of slow bull and long bull in the stock market in the future, so as to achieve the effect of 1 + 1 2 in asset allocation.

Not only quantitative CTA, stock bulls also aim at the low entry opportunity after the sharp decline of the stock market. Ten billion private placements, including juming investment, Zhengyuan investment and China Europe Ruibo, also have new product issuance plans in the near future.

heavy stock market value exceeds 8.5 billion yuan, and 10 billion private placement favors medicine and chemical industry

The 10 billion heavyweight stocks have always been concerned by investors. According to the statistics of private placement network, as of March 18, the information of 22 10 billion private placement heavyweight stocks has been exposed, appearing in the top 10 circulating shareholders of 32 listed companies, with a market value of more than 8.5 billion yuan, which are concentrated in 18 Shenwan industries such as power equipment, electronics, national defense and military industry, real estate, food and beverage.

The industry with the largest number of 10 billion private equity holdings is pharmaceutical biology and basic chemical industry, with 6 holdings. Among them, the pharmaceutical and biological stocks privately held by 10 billion include China National Medicines Corporation Ltd(600511) , Jiangsu Kanion Pharmaceutical Co.Ltd(600557) , Huasu Holdings Co.Ltd(000509) , Baicheng medicine, Apt Medical Inc(688617) , Yantai Zhenghai Bio-Tech Co.Ltd(300653) , etc. Six basic chemical stocks held by 10 billion private placement include Jiangsu Baichuan High-Tech New Materials Co.Ltd(002455) , Hunan Kaimeite Gases Co.Ltd(002549) , Rianlon Corporation(300596) , Shanghai Tianyang Hotmelt Adhesives Co.Ltd(603330) , Wanhua Chemical Group Co.Ltd(600309) , Xinjiang Zhongtai Chenical Co.Ltd(002092) , etc.

In addition, from the coincidence degree of 10 billion private placement heavy positions, China National Medicines Corporation Ltd(600511) , Kbc Corporation Ltd(688598) , Jiangsu Kanion Pharmaceutical Co.Ltd(600557) , Qingdao Tgood Electric Co.Ltd(300001) won two private placement heavy positions at the same time. Taking Qingdao Tgood Electric Co.Ltd(300001) as an example, 10 billion private placement Xuanyuan investment and minority investment hold the shares at the same time, among which "Xuanyuan Kexin No. 59" and "minority Vientiane update No. 6" have the same number of shares compared with the previous period, while Xuanyuan Kexin No. 157 has newly purchased 4228000 shares, all of which have entered the top ten circulation shareholders.

Similarly, Jiangsu Kanion Pharmaceutical Co.Ltd(600557) , which was also "crashed" in heavy position stocks, was held by 10 billion private equity Gaoyi assets and Yinye investment, with a market value of 56.165 million yuan and 28.549 million yuan respectively Jiangsu Kanion Pharmaceutical Co.Ltd(600557) is also one of the top 10 billion private placement stocks since the fourth quarter, with an increase of 41.62% as of March 18 since the fourth quarter of last year. In addition to holding Jiangsu Kanion Pharmaceutical Co.Ltd(600557) , Gaoyi assets also newly acquired Wanhua Chemical Group Co.Ltd(600309) , Apt Medical Inc(688617) , and continue to hold Rianlon Corporation(300596) . In addition, kuanyuan assets and SAIC Qizhen (Shanghai) assets have heavy positions China National Medicines Corporation Ltd(600511) , while abama assets and panze assets have heavy positions Kbc Corporation Ltd(688598) .

Jinglin asset's heavy position stocks include Chongqing Fuling Zhacai Group Co.Ltd(002507) , China Merchants Property Operation & Service Co.Ltd(001914) etc. in addition to the A-share position, Jinglin asset also submitted the US stock position at the end of the fourth quarter of last year to the US Securities and Exchange Commission (SEC) on February 11. According to the statistics of private placement network, as of the end of the fourth quarter of 2021, the market value of Jinglin asset's US stock position was US $2.696 billion, and the largest heavy position stock was sea Ltd, known as "little Tencent in Southeast Asia", with a market value of US $490 million at the end of the period, equivalent to about RMB 3.109 billion.

From the perspective of position changes, Jinglin assets copied the bottom of zhonggai Internet enterprises and new energy stocks against the trend in US stocks. At the same time, Jinglin assets also resolutely cleared its position in education stocks. According to the statistics of private placement paipai.com, the US stocks with a market value of more than US $100 million in Jinglin assets include sea Ltd, meta, Google, Netease, shell, Zhongtong express and pinduoduo, of which Zhongyu shares account for a large proportion.

From the performance of the 32 heavy warehouse stocks of billions of billions, as of March 18, as of March 18, from the end of the fourth quarter of last year last year, the average growth of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of private heavy warehouse stocks is - 3.52% on average since the fourth quarter of last year. From the perspective of the performance of 32 heavy warehouse stocks, the performance of 32 heavy warehouse stocks of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of billions of and other heavyweight stocks fell by more than 30%.

- Advertisment -